Literature DB >> 10414511

The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion.

V E Reuter, J I Epstein, M B Amin, F K Mostofi.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10414511     DOI： 10.1016/s0046-8177(99)90153-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  6 in total

1.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

2.  Clinical outcome of primary versus secondary bladder carcinoma in situ.

Authors:  Daher C Chade; Shahrokh F Shariat; Ari Adamy; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

3.  TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.

Authors:  P Sivaramakrishna Rachakonda; Ismail Hosen; Petra J de Verdier; Mahdi Fallah; Barbara Heidenreich; Charlotta Ryk; N Peter Wiklund; Gunnar Steineck; Dirk Schadendorf; Kari Hemminki; Rajiv Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

4.  TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.

Authors:  Adela Castillejo; Nathaniel Rothman; Cristiane Murta-Nascimento; Núria Malats; Montserrat García-Closas; Angeles Gómez-Martínez; Josep Lloreta; Adonina Tardón; Consol Serra; Reina García-Closas; Stephen Chanock; Debra T Silverman; Mustafa Dosemeci; Manolis Kogevinas; Alfredo Carrato; José Luis Soto; Francisco X Real
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

5.  Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.

Authors:  Charlotta Ryk; Lotta Renström Koskela; Tomas Thiel; N Peter Wiklund; Gunnar Steineck; Martin C Schumacher; Petra J de Verdier
Journal:  Redox Biol       Date:  2015-08-10       Impact factor: 11.799

6.  Staging of transitional cell carcinoma: Has anything changed?

Authors:  J N Kulkarni; G K Bakshi
Journal:  Indian J Urol       Date:  2008-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.